Oscotec Inc. (039200.KQ)
KRW 27550.0
(0.18%)
KRW 27550.0
(0.18%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 37.86 Billion KRW | 72.76% |
| 2022 | 21.91 Billion KRW | 23.26% |
| 2021 | 17.77 Billion KRW | -7.14% |
| 2020 | 19.14 Billion KRW | 6.21% |
| 2019 | 18.02 Billion KRW | -3.02% |
| 2018 | 18.58 Billion KRW | 24.83% |
| 2017 | 14.89 Billion KRW | 13.22% |
| 2016 | 13.15 Billion KRW | -45.37% |
| 2015 | 24.07 Billion KRW | 66.2% |
| 2014 | 14.48 Billion KRW | -6.44% |
| 2013 | 15.48 Billion KRW | -16.66% |
| 2012 | 18.57 Billion KRW | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 42.57 Billion KRW | 11.81% |
| 2024 Q1 | 38.07 Billion KRW | 0.57% |
| 2023 Q1 | 24 Billion KRW | 9.54% |
| 2023 FY | 37.86 Billion KRW | 72.76% |
| 2023 Q2 | 26.72 Billion KRW | 11.32% |
| 2023 Q4 | 37.86 Billion KRW | 25.23% |
| 2023 Q3 | 30.23 Billion KRW | 13.14% |
| 2022 Q4 | 21.91 Billion KRW | 2.81% |
| 2022 Q3 | 21.31 Billion KRW | 6.25% |
| 2022 Q2 | 20.06 Billion KRW | -0.88% |
| 2022 Q1 | 20.23 Billion KRW | 13.84% |
| 2022 FY | 21.91 Billion KRW | 23.26% |
| 2021 FY | 17.77 Billion KRW | -7.14% |
| 2021 Q3 | 21.86 Billion KRW | 47.07% |
| 2021 Q2 | 14.86 Billion KRW | -21.49% |
| 2021 Q1 | 18.93 Billion KRW | -1.09% |
| 2021 Q4 | 17.77 Billion KRW | -18.7% |
| 2020 Q2 | 18.24 Billion KRW | -10.53% |
| 2020 Q1 | 20.38 Billion KRW | 13.09% |
| 2020 FY | 19.14 Billion KRW | 6.21% |
| 2020 Q4 | 19.14 Billion KRW | 19.29% |
| 2020 Q3 | 16.05 Billion KRW | -12.0% |
| 2019 Q1 | 17.37 Billion KRW | -6.52% |
| 2019 FY | 18.02 Billion KRW | -3.02% |
| 2019 Q4 | 18.02 Billion KRW | -22.94% |
| 2019 Q3 | 23.39 Billion KRW | -1.09% |
| 2019 Q2 | 23.65 Billion KRW | 36.11% |
| 2018 Q3 | 23.57 Billion KRW | 67.12% |
| 2018 Q2 | 14.1 Billion KRW | 1.37% |
| 2018 Q1 | 13.91 Billion KRW | -6.55% |
| 2018 FY | 18.58 Billion KRW | 24.83% |
| 2018 Q4 | 18.58 Billion KRW | -21.15% |
| 2017 FY | 14.89 Billion KRW | 13.22% |
| 2017 Q2 | 8.34 Billion KRW | -29.87% |
| 2017 Q4 | 14.89 Billion KRW | 96.56% |
| 2017 Q3 | 7.57 Billion KRW | -9.16% |
| 2017 Q1 | 11.89 Billion KRW | -1.33% |
| 2016 Q3 | 14.26 Billion KRW | -5.24% |
| 2016 FY | 13.15 Billion KRW | -45.37% |
| 2016 Q4 | 12.05 Billion KRW | -15.52% |
| 2016 Q2 | 15.05 Billion KRW | -26.98% |
| 2016 Q1 | 20.61 Billion KRW | -5.26% |
| 2015 Q3 | 14.67 Billion KRW | 3.41% |
| 2015 Q2 | 14.18 Billion KRW | 4.65% |
| 2015 Q1 | 13.55 Billion KRW | -6.41% |
| 2015 FY | 24.07 Billion KRW | 66.2% |
| 2015 Q4 | 21.76 Billion KRW | 48.33% |
| 2014 Q4 | 14.48 Billion KRW | 3.56% |
| 2014 Q3 | 13.98 Billion KRW | 0.75% |
| 2014 Q2 | 13.88 Billion KRW | 0.62% |
| 2014 Q1 | 13.79 Billion KRW | -10.88% |
| 2014 FY | 14.48 Billion KRW | -6.44% |
| 2013 Q4 | 15.48 Billion KRW | -1.78% |
| 2013 FY | 15.48 Billion KRW | -16.66% |
| 2013 Q3 | 15.76 Billion KRW | -1.71% |
| 2013 Q2 | 16.03 Billion KRW | -8.2% |
| 2013 Q1 | 17.46 Billion KRW | -5.97% |
| 2012 FY | 18.57 Billion KRW | 0.0% |
| 2012 Q4 | 18.57 Billion KRW | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| BCWORLD PHARM. Co., Ltd. | 104.24 Billion KRW | 63.68% |